152 related articles for article (PubMed ID: 15771901)
21. MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors.
Peter M; Rosty C; Couturier J; Radvanyi F; Teshima H; Sastre-Garau X
Oncogene; 2006 Sep; 25(44):5985-93. PubMed ID: 16682952
[TBL] [Abstract][Full Text] [Related]
22. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
[TBL] [Abstract][Full Text] [Related]
23. [Sequence polymorphism of human papillomavirus type 16 E7 in cervical cancer].
Liu X; Liu GB; Pang ZJ; Xing FQ
Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1272-5. PubMed ID: 16234107
[TBL] [Abstract][Full Text] [Related]
24. HPV type 18 is more oncopotent than HPV16 in uterine cervical carcinogenesis although HPV16 is the prevalent type in Chennai, India.
Berlin Grace VM
Indian J Cancer; 2009; 46(3):203-7. PubMed ID: 19574671
[TBL] [Abstract][Full Text] [Related]
25. A recurrent human papillomavirus integration site at chromosome region 12q14-q15 in SW756 and SK-v cell lines derived from genital tumors.
Sastre-Garau X; Couturier J; Favre M; Orth G
C R Acad Sci III; 1995 Apr; 318(4):475-8. PubMed ID: 7648359
[TBL] [Abstract][Full Text] [Related]
26. [Detection of physical status of human papillomavirus 16 in cervical cancer tissue and SiHa cell line by multiplex real-time polymerase chain reaction].
Zheng Y; Peng ZL; Lou JY; Wang H
Ai Zheng; 2006 Mar; 25(3):373-7. PubMed ID: 16536998
[TBL] [Abstract][Full Text] [Related]
27. Human papillomavirus infection and P53 codon 72 genotypes in a Hispanic population at high-risk for cervical cancer.
Haws AL; Woeber S; Gomez M; Garza N; Gomez Y; Rady P; He Q; Zhang L; Grady JJ; McCormick JB; Fisher-Hoch SP; Tyring SK
J Med Virol; 2005 Oct; 77(2):265-72. PubMed ID: 16121365
[TBL] [Abstract][Full Text] [Related]
28. Low-risk human papillomavirus type 6 DNA load and integration in cervical samples from women with squamous intraepithelial lesions.
Coutlée F; Trottier H; Gagnon S; Koushik A; Richardson H; Roger M; Ferenczy AS; Franco EL
J Clin Virol; 2009 Jun; 45(2):96-9. PubMed ID: 19398216
[TBL] [Abstract][Full Text] [Related]
29. Preferential sites for the integration and disruption of human papillomavirus 16 in cervical lesions.
Li H; Yang Y; Zhang R; Cai Y; Yang X; Wang Z; Li Y; Cheng X; Ye X; Xiang Y; Zhu B
J Clin Virol; 2013 Apr; 56(4):342-7. PubMed ID: 23290390
[TBL] [Abstract][Full Text] [Related]
30. Genomic organization of amplified MYC genes suggests distinct mechanisms of amplification in tumorigenesis.
Herrick J; Conti C; Teissier S; Thierry F; Couturier J; Sastre-Garau X; Favre M; Orth G; Bensimon A
Cancer Res; 2005 Feb; 65(4):1174-9. PubMed ID: 15735000
[TBL] [Abstract][Full Text] [Related]
31. Single or multiple HPV types in cervical cancer and associated metastases.
Ciotti M; Paba P; Bonifacio D; Di Bonito L; Benedetto A; Favalli C
Oncol Rep; 2006 Jan; 15(1):143-8. PubMed ID: 16328047
[TBL] [Abstract][Full Text] [Related]
32. [Integrating HPV testing for primary screening?].
Riethmuller D; Ramanah R; Pretet JL; Mougin C
J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S139-51. PubMed ID: 18191912
[TBL] [Abstract][Full Text] [Related]
33. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
[TBL] [Abstract][Full Text] [Related]
34. Genital human papillomavirus infection.
Dunne EF; Markowitz LE
Clin Infect Dis; 2006 Sep; 43(5):624-9. PubMed ID: 16886157
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus subtype 16 is common in Pakistani women with cervical carcinoma.
Khan S; Jaffer NN; Khan MN; Rai MA; Shafiq M; Ali A; Pervez S; Khan N; Aziz A; Ali SH
Int J Infect Dis; 2007 Jul; 11(4):313-7. PubMed ID: 17291804
[TBL] [Abstract][Full Text] [Related]
36. The performance of the HPV16 real-time PCR integration assay.
Ruutu MP; Kulmala SM; Peitsaro P; Syrjänen SM
Clin Biochem; 2008 Apr; 41(6):423-8. PubMed ID: 18206116
[TBL] [Abstract][Full Text] [Related]
37. Expression of p16(INK4A), p53, and Rb proteins are independent from the presence of human papillomavirus genes in oral squamous cell carcinoma.
Nemes JA; Deli L; Nemes Z; Márton IJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Sep; 102(3):344-52. PubMed ID: 16920543
[TBL] [Abstract][Full Text] [Related]
38. Distribution of human papillomavirus genotypes in women with cervical cancer in Slovenia.
Jancar N; Kocjan BJ; Poljak M; Lunar MM; Bokal EV
Eur J Obstet Gynecol Reprod Biol; 2009 Aug; 145(2):184-8. PubMed ID: 19477061
[TBL] [Abstract][Full Text] [Related]
39. A pilot study on the distribution of human papillomavirus genotypes and HPV-16 variants in cervical neoplastic lesions from Ecuadorian women.
Tornesello ML; Buonaguro L; Izzo S; Lopez G; Vega X; Maldonado Reyes CF; Buonaguro FM
J Med Virol; 2008 Nov; 80(11):1959-65. PubMed ID: 18814248
[TBL] [Abstract][Full Text] [Related]
40. Human papillomavirus localization in cervical adenocarcinoma and adenosquamous carcinoma using in situ polymerase chain reaction: review of the literature of human papillomavirus detection in these carcinomas.
Ogura K; Ishi K; Matsumoto T; Kina K; Nojima M; Suda K
Pathol Int; 2006 Jun; 56(6):301-8. PubMed ID: 16704493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]